Price to Sales ratio Analysis of Aprea Therapeutics Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
29.59
Period Ending - Dec-22
Very Poor PS
0
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
19.06
PS Analysis of Aprea Therapeutics Inc
P/S Ratio of Aprea Therapeutics Inc with value of 19.06 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of APRE has grown by 0 % Compared to previous Financial Year. |
PS Ratio with value of 29.59 was highest in Year Dec-23 in last Five Years. |
PS Ratio with value of 0 was lowest in Year Dec-22 in last Five Years. |
Latest PS Ratio with value of 29.59 is Greater than Average PS of 5.92 in last five years. |
Other PS Related Info of APRE that may interest you.
Aprea Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
APRE | 4.77 | 4.607 | 3.54 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Very Low Value Stock |
FY - Historical Price to Sales of Aprea Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 29.59 | 0 | 0 | 0 | 0 | 0 | 0 |
Change |
FY Chart of Price to Sales of Aprea Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)